We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Genetic Drivers Discovered for DiGeorge Syndrome Kidney Defects

By LabMedica International staff writers
Posted on 10 Feb 2017
DiGeorge syndrome is a chromosomal disorder that can lead to malformations in multiple organs and it is the most common microdeletion syndrome, in which a portion of a chromosome is missing.

The DiGeorge syndrome is a debilitating, multisystemic condition that features, with variable expressivity, cardiac malformations, velopharyngeal insufficiency, hypoparathyroidism with hypocalcemia, and thymic aplasia with immune deficiency.

Image: A diagram depicting the deletion and some of the genes in the DiGeorge syndrome locus (Photo courtesy of Genetics 4 Medics).
Image: A diagram depicting the deletion and some of the genes in the DiGeorge syndrome locus (Photo courtesy of Genetics 4 Medics).

A large team of scientists led by those at Columbia University Medical Center performed genomic analyses in 2,666 children with congenital anomalies of the kidney and urinary tract which is the largest pediatric cohort of these disorders, and 22,094 controls to identify structural variants associated with these defects. They performed genomewide genotyping for analysis of copy-number variation by means of high-density single-nucleotide polymorphism (SNP) microarrays.

They performed high-throughput next-generation sequencing for eight genes in the 370-kb minimal region of overlap for the DiGeorge syndrome in samples obtained from an additional 526 patients using microfluidic polymerase-chain-reaction capture coupled with next-generation sequencing on the 2500 HiSeq system.

The scientists’ analysis identified deletions at the terminal portion of the 22q11.2 DiGeorge locus as the second most common microdeletion in patients with kidney malformations. This study mapped the candidate gene for kidney disease in DiGeorge syndrome to a smaller region containing only nine genes. The team resequenced all genes included in the critical 22q11.2 region identified five out of 586 patients with kidney and urinary tract defects that had novel heterozygous protein-altering variants, including a premature termination codon, in CRK-Like Proto-Oncogene, Adaptor Protein gene (CRKL). Inactivation of the same gene in mouse embryos finally proved its role as the main driver.

Simone Sanna-Cherchi, MD, an assistant professor of medicine and senior author of the study said, “This study represents a critical step forward in understanding the genetic basis of congenital kidney defects associated with DiGeorge syndrome and in the general population. Expanding our knowledge of the genetics of kidney development and malformations will give us additional tools needed to diagnose this variant of DiGeorge syndrome and gives us a potential therapeutic target.” The study was published on January 25, 2017, in The New England Journal of Medicine.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Latest Molecular Diagnostics News

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Fluid Biomarker Test Detects Neurodegenerative Diseases Before Symptoms Appear